Loading...
•
Sep 30, 2024
Health Catalyst Q3 2024 Earnings Report
Reported strong financial results with revenue of $76.4 million and Adjusted EBITDA of $7.3 million, exceeding guidance.
Key Takeaways
Health Catalyst reported strong financial results for Q3 2024, with total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, both exceeding the midpoint of their quarterly guidance. They are raising their Adjusted EBITDA guidance by $1 million for 2024.
Total revenue reached $76.4 million.
Adjusted EBITDA was $7.3 million.
Adjusted EBITDA guidance raised by $1 million for 2024.
Company is focused on driving profitable growth and scaling.
Health Catalyst
Health Catalyst
Health Catalyst Revenue by Segment
Revenue by Segment
Technology Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA. For the fourth quarter of 2024, they expect total revenue between $78.0 million and $84.0 million, and Adjusted EBITDA between $6.8 million and $8.8 million. For the full year of 2024, they expect total revenue between $305.0 million and $311.0 million, and Adjusted EBITDA between $25.0 million and $27.0 million.
Positive Outlook
- Total revenue between $78.0 million and $84.0 million for Q4 2024.
- Adjusted EBITDA between $6.8 million and $8.8 million for Q4 2024.
- Total revenue between $305.0 million and $311.0 million for the full year 2024.
- Adjusted EBITDA between $25.0 million and $27.0 million for the full year 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income